+30.1%
MRNA vs AMDL
+131.0%
-100.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | AMDL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +6.0% | -9.4% | -4.0% |
| 7D | -10.1% | +29.0% | -39.0% | -12.7% |
| 30D | +126.7% | +19.1% | +107.7% | +120.1% |
| 3M | +184.1% | +1.8% | +182.3% | +171.5% |
| 6M | +143.3% | +374.4% | -231.1% | +76.6% |
| YTD | +359.9% | +278.9% | +80.9% | +237.7% |
| 1Y | +454.2% | +510.6% | -56.4% | +260.5% |
| All | +30.1% | +131.0% | -100.9% | -19.3% |
Cumulative growth
Daily Returns
Daily percentage return beside AMDL.
Daily Out/Under-Performance
Portfolio return minus AMDL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMDL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded AMDL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling